MATINAS BIOPHARMA HOLDINGS, INC. UP TO $50,000,000 OF COMMON STOCK (par value $0.0001 per share) At-the-market SALES AGREEMENTAt-the-Market Sales Agreement • July 2nd, 2020 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 2nd, 2020 Company Industry JurisdictionMatinas Biopharma Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with BTIG, LLC (“BTIG” and, together with the Company, the “Parties”), as follows: